A novel anti‐inflammatory role for secretory phospholipase A2 in immune complex‐mediated arthritis

Phospholipase A 2 (PLA 2 ) catalyses the release of arachidonic acid for generation of lipid mediators of inflammation and is crucial in diverse inflammatory processes. The functions of the secretory PLA 2 enzymes (sPLA 2 ), numbering nine members in humans, are poorly understood, though they have b...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:EMBO molecular medicine 2010-05, Vol.2 (5), p.172-187
Hauptverfasser: Boilard, Eric, Lai, Ying, Larabee, Katherine, Balestrieri, Barbara, Ghomashchi, Farideh, Fujioka, Daisuke, Gobezie, Reuben, Coblyn, Jonathan S., Weinblatt, Michael E., Massarotti, Elena M., Thornhill, Thomas S., Divangahi, Maziar, Remold, Heinz, Lambeau, Gérard, Gelb, Michael H., Arm, Jonathan P., Lee, David M.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 187
container_issue 5
container_start_page 172
container_title EMBO molecular medicine
container_volume 2
creator Boilard, Eric
Lai, Ying
Larabee, Katherine
Balestrieri, Barbara
Ghomashchi, Farideh
Fujioka, Daisuke
Gobezie, Reuben
Coblyn, Jonathan S.
Weinblatt, Michael E.
Massarotti, Elena M.
Thornhill, Thomas S.
Divangahi, Maziar
Remold, Heinz
Lambeau, Gérard
Gelb, Michael H.
Arm, Jonathan P.
Lee, David M.
description Phospholipase A 2 (PLA 2 ) catalyses the release of arachidonic acid for generation of lipid mediators of inflammation and is crucial in diverse inflammatory processes. The functions of the secretory PLA 2 enzymes (sPLA 2 ), numbering nine members in humans, are poorly understood, though they have been shown to participate in lipid mediator generation and the associated inflammation. To further understand the roles of sPLA 2 in disease, we quantified the expression of these enzymes in the synovial fluid in rheumatoid arthritis and used gene‐deleted mice to examine their contribution in a mouse model of autoimmune erosive inflammatory arthritis. Contrary to expectation, we find that the group V sPLA 2 isoform plays a novel anti‐inflammatory role that opposes the pro‐inflammatory activity of group IIA sPLA 2 . Mechanistically, group V sPLA 2 counter‐regulation includes promotion of immune complex clearance by regulating cysteinyl leukotriene synthesis. These observations identify a novel anti‐inflammatory function for a PLA 2 and identify group V sPLA 2 as a potential biotherapeutic for treatment of immune‐complex‐mediated inflammation.
doi_str_mv 10.1002/emmm.201000072
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3058614</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>733316744</sourcerecordid><originalsourceid>FETCH-LOGICAL-h4102-f5f05c9ea3aeff35cf81aea9634f6a866e82e08869b33848d4c889c138db7e283</originalsourceid><addsrcrecordid>eNp1kctu1DAUhiMEoqWwZYm8Qyym9S2Os0EaVYUizYgNrC1P5rhx5Uuwkymz6yP0GXkSPEyJAImF5XP7Px_5r6rXBJ8TjOkFeO_PKS4xxg19Up2Spm4WXEj-dI4bcVK9yPkWY1ELIp9XJxRzRmvMTiuzRCHuwCEdRvvj_sEG47T3eoxpj1J0gExMKEOX4Fdp6GMux9lBZ0BLimxA1vspAOqiHxx8LxAPW6tH2CKdxj7Z0eaX1TOjXYZXj_dZ9fXD1ZfL68Xq88dPl8vVoucE04WpDa67FjTTYAyrOyOJBt0Kxo3QUgiQFLCUot0wJrnc8k7KtiNMbjcNUMnOqvdH7jBtyhYdhDFpp4ZkvU57FbVVf3eC7dVN3CmGaykIL4B3R0D_j-x6uVKHGsa8bQQjO1Jm3z4-luK3CfKovM0dOKcDxCmrhjFGRMMP1Dd_rjWDf_tQBtrjwJ11sJ_7BKuDy-rgsppdVlfr9XrOivbiqM1FFm4gqds4pVC--T969hNuFq6f</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>733316744</pqid></control><display><type>article</type><title>A novel anti‐inflammatory role for secretory phospholipase A2 in immune complex‐mediated arthritis</title><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>Wiley-Blackwell Open Access Titles</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Wiley Online Library All Journals</source><source>PubMed Central</source><creator>Boilard, Eric ; Lai, Ying ; Larabee, Katherine ; Balestrieri, Barbara ; Ghomashchi, Farideh ; Fujioka, Daisuke ; Gobezie, Reuben ; Coblyn, Jonathan S. ; Weinblatt, Michael E. ; Massarotti, Elena M. ; Thornhill, Thomas S. ; Divangahi, Maziar ; Remold, Heinz ; Lambeau, Gérard ; Gelb, Michael H. ; Arm, Jonathan P. ; Lee, David M.</creator><creatorcontrib>Boilard, Eric ; Lai, Ying ; Larabee, Katherine ; Balestrieri, Barbara ; Ghomashchi, Farideh ; Fujioka, Daisuke ; Gobezie, Reuben ; Coblyn, Jonathan S. ; Weinblatt, Michael E. ; Massarotti, Elena M. ; Thornhill, Thomas S. ; Divangahi, Maziar ; Remold, Heinz ; Lambeau, Gérard ; Gelb, Michael H. ; Arm, Jonathan P. ; Lee, David M.</creatorcontrib><description>Phospholipase A 2 (PLA 2 ) catalyses the release of arachidonic acid for generation of lipid mediators of inflammation and is crucial in diverse inflammatory processes. The functions of the secretory PLA 2 enzymes (sPLA 2 ), numbering nine members in humans, are poorly understood, though they have been shown to participate in lipid mediator generation and the associated inflammation. To further understand the roles of sPLA 2 in disease, we quantified the expression of these enzymes in the synovial fluid in rheumatoid arthritis and used gene‐deleted mice to examine their contribution in a mouse model of autoimmune erosive inflammatory arthritis. Contrary to expectation, we find that the group V sPLA 2 isoform plays a novel anti‐inflammatory role that opposes the pro‐inflammatory activity of group IIA sPLA 2 . Mechanistically, group V sPLA 2 counter‐regulation includes promotion of immune complex clearance by regulating cysteinyl leukotriene synthesis. These observations identify a novel anti‐inflammatory function for a PLA 2 and identify group V sPLA 2 as a potential biotherapeutic for treatment of immune‐complex‐mediated inflammation.</description><identifier>ISSN: 1757-4676</identifier><identifier>EISSN: 1757-4684</identifier><identifier>DOI: 10.1002/emmm.201000072</identifier><identifier>PMID: 20432503</identifier><language>eng</language><publisher>London: Nature Publishing Group UK</publisher><subject>Animals ; Anti-Inflammatory Agents - immunology ; Antigen-Antibody Complex - immunology ; arthritis ; Arthritis, Rheumatoid - enzymology ; Arthritis, Rheumatoid - genetics ; Arthritis, Rheumatoid - immunology ; autoimmunity ; Disease Models, Animal ; Female ; Human health and pathology ; Humans ; inflammation ; Life Sciences ; Male ; Mice ; Mice, Inbred BALB C ; Mice, Inbred C57BL ; Mice, Knockout ; Phospholipases A2, Secretory - genetics ; Phospholipases A2, Secretory - immunology ; Research Article ; secreted phospholipase A2 ; Synovial Fluid - enzymology ; Synovial Fluid - immunology</subject><ispartof>EMBO molecular medicine, 2010-05, Vol.2 (5), p.172-187</ispartof><rights>EMBO Molecular Medicine 2010</rights><rights>Copyright © 2010 EMBO Molecular Medicine</rights><rights>Distributed under a Creative Commons Attribution 4.0 International License</rights><rights>Copyright © 2010 EMBO Molecular Medicine 2010</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><orcidid>0000-0001-6319-6432 ; 0000-0002-9239-518X</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3058614/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3058614/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,864,885,1416,11560,27922,27923,45572,45573,46050,46474,53789,53791</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20432503$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://hal.science/hal-00497631$$DView record in HAL$$Hfree_for_read</backlink></links><search><creatorcontrib>Boilard, Eric</creatorcontrib><creatorcontrib>Lai, Ying</creatorcontrib><creatorcontrib>Larabee, Katherine</creatorcontrib><creatorcontrib>Balestrieri, Barbara</creatorcontrib><creatorcontrib>Ghomashchi, Farideh</creatorcontrib><creatorcontrib>Fujioka, Daisuke</creatorcontrib><creatorcontrib>Gobezie, Reuben</creatorcontrib><creatorcontrib>Coblyn, Jonathan S.</creatorcontrib><creatorcontrib>Weinblatt, Michael E.</creatorcontrib><creatorcontrib>Massarotti, Elena M.</creatorcontrib><creatorcontrib>Thornhill, Thomas S.</creatorcontrib><creatorcontrib>Divangahi, Maziar</creatorcontrib><creatorcontrib>Remold, Heinz</creatorcontrib><creatorcontrib>Lambeau, Gérard</creatorcontrib><creatorcontrib>Gelb, Michael H.</creatorcontrib><creatorcontrib>Arm, Jonathan P.</creatorcontrib><creatorcontrib>Lee, David M.</creatorcontrib><title>A novel anti‐inflammatory role for secretory phospholipase A2 in immune complex‐mediated arthritis</title><title>EMBO molecular medicine</title><addtitle>EMBO Mol Med</addtitle><addtitle>EMBO Mol Med</addtitle><description>Phospholipase A 2 (PLA 2 ) catalyses the release of arachidonic acid for generation of lipid mediators of inflammation and is crucial in diverse inflammatory processes. The functions of the secretory PLA 2 enzymes (sPLA 2 ), numbering nine members in humans, are poorly understood, though they have been shown to participate in lipid mediator generation and the associated inflammation. To further understand the roles of sPLA 2 in disease, we quantified the expression of these enzymes in the synovial fluid in rheumatoid arthritis and used gene‐deleted mice to examine their contribution in a mouse model of autoimmune erosive inflammatory arthritis. Contrary to expectation, we find that the group V sPLA 2 isoform plays a novel anti‐inflammatory role that opposes the pro‐inflammatory activity of group IIA sPLA 2 . Mechanistically, group V sPLA 2 counter‐regulation includes promotion of immune complex clearance by regulating cysteinyl leukotriene synthesis. These observations identify a novel anti‐inflammatory function for a PLA 2 and identify group V sPLA 2 as a potential biotherapeutic for treatment of immune‐complex‐mediated inflammation.</description><subject>Animals</subject><subject>Anti-Inflammatory Agents - immunology</subject><subject>Antigen-Antibody Complex - immunology</subject><subject>arthritis</subject><subject>Arthritis, Rheumatoid - enzymology</subject><subject>Arthritis, Rheumatoid - genetics</subject><subject>Arthritis, Rheumatoid - immunology</subject><subject>autoimmunity</subject><subject>Disease Models, Animal</subject><subject>Female</subject><subject>Human health and pathology</subject><subject>Humans</subject><subject>inflammation</subject><subject>Life Sciences</subject><subject>Male</subject><subject>Mice</subject><subject>Mice, Inbred BALB C</subject><subject>Mice, Inbred C57BL</subject><subject>Mice, Knockout</subject><subject>Phospholipases A2, Secretory - genetics</subject><subject>Phospholipases A2, Secretory - immunology</subject><subject>Research Article</subject><subject>secreted phospholipase A2</subject><subject>Synovial Fluid - enzymology</subject><subject>Synovial Fluid - immunology</subject><issn>1757-4676</issn><issn>1757-4684</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><sourceid>24P</sourceid><sourceid>WIN</sourceid><sourceid>EIF</sourceid><recordid>eNp1kctu1DAUhiMEoqWwZYm8Qyym9S2Os0EaVYUizYgNrC1P5rhx5Uuwkymz6yP0GXkSPEyJAImF5XP7Px_5r6rXBJ8TjOkFeO_PKS4xxg19Up2Spm4WXEj-dI4bcVK9yPkWY1ELIp9XJxRzRmvMTiuzRCHuwCEdRvvj_sEG47T3eoxpj1J0gExMKEOX4Fdp6GMux9lBZ0BLimxA1vspAOqiHxx8LxAPW6tH2CKdxj7Z0eaX1TOjXYZXj_dZ9fXD1ZfL68Xq88dPl8vVoucE04WpDa67FjTTYAyrOyOJBt0Kxo3QUgiQFLCUot0wJrnc8k7KtiNMbjcNUMnOqvdH7jBtyhYdhDFpp4ZkvU57FbVVf3eC7dVN3CmGaykIL4B3R0D_j-x6uVKHGsa8bQQjO1Jm3z4-luK3CfKovM0dOKcDxCmrhjFGRMMP1Dd_rjWDf_tQBtrjwJ11sJ_7BKuDy-rgsppdVlfr9XrOivbiqM1FFm4gqds4pVC--T969hNuFq6f</recordid><startdate>20100501</startdate><enddate>20100501</enddate><creator>Boilard, Eric</creator><creator>Lai, Ying</creator><creator>Larabee, Katherine</creator><creator>Balestrieri, Barbara</creator><creator>Ghomashchi, Farideh</creator><creator>Fujioka, Daisuke</creator><creator>Gobezie, Reuben</creator><creator>Coblyn, Jonathan S.</creator><creator>Weinblatt, Michael E.</creator><creator>Massarotti, Elena M.</creator><creator>Thornhill, Thomas S.</creator><creator>Divangahi, Maziar</creator><creator>Remold, Heinz</creator><creator>Lambeau, Gérard</creator><creator>Gelb, Michael H.</creator><creator>Arm, Jonathan P.</creator><creator>Lee, David M.</creator><general>Nature Publishing Group UK</general><general>WILEY‐VCH Verlag</general><general>Wiley Open Access</general><general>WILEY-VCH Verlag</general><scope>24P</scope><scope>WIN</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope><scope>1XC</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0001-6319-6432</orcidid><orcidid>https://orcid.org/0000-0002-9239-518X</orcidid></search><sort><creationdate>20100501</creationdate><title>A novel anti‐inflammatory role for secretory phospholipase A2 in immune complex‐mediated arthritis</title><author>Boilard, Eric ; Lai, Ying ; Larabee, Katherine ; Balestrieri, Barbara ; Ghomashchi, Farideh ; Fujioka, Daisuke ; Gobezie, Reuben ; Coblyn, Jonathan S. ; Weinblatt, Michael E. ; Massarotti, Elena M. ; Thornhill, Thomas S. ; Divangahi, Maziar ; Remold, Heinz ; Lambeau, Gérard ; Gelb, Michael H. ; Arm, Jonathan P. ; Lee, David M.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-h4102-f5f05c9ea3aeff35cf81aea9634f6a866e82e08869b33848d4c889c138db7e283</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Animals</topic><topic>Anti-Inflammatory Agents - immunology</topic><topic>Antigen-Antibody Complex - immunology</topic><topic>arthritis</topic><topic>Arthritis, Rheumatoid - enzymology</topic><topic>Arthritis, Rheumatoid - genetics</topic><topic>Arthritis, Rheumatoid - immunology</topic><topic>autoimmunity</topic><topic>Disease Models, Animal</topic><topic>Female</topic><topic>Human health and pathology</topic><topic>Humans</topic><topic>inflammation</topic><topic>Life Sciences</topic><topic>Male</topic><topic>Mice</topic><topic>Mice, Inbred BALB C</topic><topic>Mice, Inbred C57BL</topic><topic>Mice, Knockout</topic><topic>Phospholipases A2, Secretory - genetics</topic><topic>Phospholipases A2, Secretory - immunology</topic><topic>Research Article</topic><topic>secreted phospholipase A2</topic><topic>Synovial Fluid - enzymology</topic><topic>Synovial Fluid - immunology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Boilard, Eric</creatorcontrib><creatorcontrib>Lai, Ying</creatorcontrib><creatorcontrib>Larabee, Katherine</creatorcontrib><creatorcontrib>Balestrieri, Barbara</creatorcontrib><creatorcontrib>Ghomashchi, Farideh</creatorcontrib><creatorcontrib>Fujioka, Daisuke</creatorcontrib><creatorcontrib>Gobezie, Reuben</creatorcontrib><creatorcontrib>Coblyn, Jonathan S.</creatorcontrib><creatorcontrib>Weinblatt, Michael E.</creatorcontrib><creatorcontrib>Massarotti, Elena M.</creatorcontrib><creatorcontrib>Thornhill, Thomas S.</creatorcontrib><creatorcontrib>Divangahi, Maziar</creatorcontrib><creatorcontrib>Remold, Heinz</creatorcontrib><creatorcontrib>Lambeau, Gérard</creatorcontrib><creatorcontrib>Gelb, Michael H.</creatorcontrib><creatorcontrib>Arm, Jonathan P.</creatorcontrib><creatorcontrib>Lee, David M.</creatorcontrib><collection>Wiley-Blackwell Open Access Titles</collection><collection>Wiley Free Content</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><collection>Hyper Article en Ligne (HAL)</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>EMBO molecular medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Boilard, Eric</au><au>Lai, Ying</au><au>Larabee, Katherine</au><au>Balestrieri, Barbara</au><au>Ghomashchi, Farideh</au><au>Fujioka, Daisuke</au><au>Gobezie, Reuben</au><au>Coblyn, Jonathan S.</au><au>Weinblatt, Michael E.</au><au>Massarotti, Elena M.</au><au>Thornhill, Thomas S.</au><au>Divangahi, Maziar</au><au>Remold, Heinz</au><au>Lambeau, Gérard</au><au>Gelb, Michael H.</au><au>Arm, Jonathan P.</au><au>Lee, David M.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A novel anti‐inflammatory role for secretory phospholipase A2 in immune complex‐mediated arthritis</atitle><jtitle>EMBO molecular medicine</jtitle><stitle>EMBO Mol Med</stitle><addtitle>EMBO Mol Med</addtitle><date>2010-05-01</date><risdate>2010</risdate><volume>2</volume><issue>5</issue><spage>172</spage><epage>187</epage><pages>172-187</pages><issn>1757-4676</issn><eissn>1757-4684</eissn><abstract>Phospholipase A 2 (PLA 2 ) catalyses the release of arachidonic acid for generation of lipid mediators of inflammation and is crucial in diverse inflammatory processes. The functions of the secretory PLA 2 enzymes (sPLA 2 ), numbering nine members in humans, are poorly understood, though they have been shown to participate in lipid mediator generation and the associated inflammation. To further understand the roles of sPLA 2 in disease, we quantified the expression of these enzymes in the synovial fluid in rheumatoid arthritis and used gene‐deleted mice to examine their contribution in a mouse model of autoimmune erosive inflammatory arthritis. Contrary to expectation, we find that the group V sPLA 2 isoform plays a novel anti‐inflammatory role that opposes the pro‐inflammatory activity of group IIA sPLA 2 . Mechanistically, group V sPLA 2 counter‐regulation includes promotion of immune complex clearance by regulating cysteinyl leukotriene synthesis. These observations identify a novel anti‐inflammatory function for a PLA 2 and identify group V sPLA 2 as a potential biotherapeutic for treatment of immune‐complex‐mediated inflammation.</abstract><cop>London</cop><pub>Nature Publishing Group UK</pub><pmid>20432503</pmid><doi>10.1002/emmm.201000072</doi><tpages>16</tpages><orcidid>https://orcid.org/0000-0001-6319-6432</orcidid><orcidid>https://orcid.org/0000-0002-9239-518X</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1757-4676
ispartof EMBO molecular medicine, 2010-05, Vol.2 (5), p.172-187
issn 1757-4676
1757-4684
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3058614
source MEDLINE; DOAJ Directory of Open Access Journals; Wiley-Blackwell Open Access Titles; EZB-FREE-00999 freely available EZB journals; Wiley Online Library All Journals; PubMed Central
subjects Animals
Anti-Inflammatory Agents - immunology
Antigen-Antibody Complex - immunology
arthritis
Arthritis, Rheumatoid - enzymology
Arthritis, Rheumatoid - genetics
Arthritis, Rheumatoid - immunology
autoimmunity
Disease Models, Animal
Female
Human health and pathology
Humans
inflammation
Life Sciences
Male
Mice
Mice, Inbred BALB C
Mice, Inbred C57BL
Mice, Knockout
Phospholipases A2, Secretory - genetics
Phospholipases A2, Secretory - immunology
Research Article
secreted phospholipase A2
Synovial Fluid - enzymology
Synovial Fluid - immunology
title A novel anti‐inflammatory role for secretory phospholipase A2 in immune complex‐mediated arthritis
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-09T13%3A13%3A55IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20novel%20anti%E2%80%90inflammatory%20role%20for%20secretory%20phospholipase%20A2%20in%20immune%20complex%E2%80%90mediated%20arthritis&rft.jtitle=EMBO%20molecular%20medicine&rft.au=Boilard,%20Eric&rft.date=2010-05-01&rft.volume=2&rft.issue=5&rft.spage=172&rft.epage=187&rft.pages=172-187&rft.issn=1757-4676&rft.eissn=1757-4684&rft_id=info:doi/10.1002/emmm.201000072&rft_dat=%3Cproquest_pubme%3E733316744%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=733316744&rft_id=info:pmid/20432503&rfr_iscdi=true